欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/0279/001
药品名称
Daivobet
活性成分
betamethasone dipropionate 0.5 mg/g
calcipotriol hydrate 50.0 µg/g
剂型
Ointment
上市许可持有人
LEO Pharma A/S Industriparken 55 2750 Ballerup Denmark
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
Ireland (IE)
France (FR)
Spain (ES)
DAIVOBET Pomada
Portugal (PT)
Daivobet
Italy (IT)
Norway (NO)
Finland (FI)
Sweden (SE)
Daivobet
Slovenia (SI)
Poland (PL)
Daivobet
Latvia (LV)
Malta (MT)
Lithuania (LT)
Daivobet 50 mikrogramų/0,5 mg/g tepalas
Estonia (EE)
Hungary (HU)
Daivobet kenőcs
Cyprus (CY)
DOVOBET OINTMENT
Romania (RO)
Daivobet 50 micrograme/ 0.5 mg/g unguent
Germany (DE)
Daivobet Salbe
Belgium (BE)
Netherlands (NL)
Luxembourg (LU)
Iceland (IS)
许可日期
2001/11/27
最近更新日期
2024/04/22
药物ATC编码
D07XC01 betamethasone
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Fixed Combination Article 4.8b
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
0279_001_pl_clean_english
Date of last change:2024/09/06
Final SPC
|
0279_001_spc_clean_english
Date of last change:2024/09/06
Final Labelling
|
DK_H_0279_001 lbl_clean_daivobet ointment _ common english
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase